Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Recruiting

NanodropperNanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Sponsor:

59th Medical Wing

Code:

NCT05844384

Conditions

Ocular Hypertension

Primary Open Angle Glaucoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nanodropper

Regular dropper

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by 59th Medical Wing on 2023-05-06.